Shanghai, China

Qing Zhou

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Qing Zhou: Innovator in Biopharmaceuticals and Materials Science

Introduction

Qing Zhou is a prominent inventor based in Shanghai, China, known for her contributions to the fields of biopharmaceuticals and materials science. With a total of five patents to her name, she has made significant strides in developing innovative solutions that address critical health and material challenges.

Latest Patents

Among her latest patents is the "Human CD47-targeting single-domain antibody and use thereof." This application relates to an anti-CD47 single-domain antibody, which includes a method for preparing the antibody. The single-domain antibody comprises specific CDRs selected from designated sequences. Another notable patent is for "Bioactive glass compositions," which details a silicate-based glass composition with precise weight percentages of various oxides, aimed at enhancing material properties for biomedical applications.

Career Highlights

Qing Zhou has worked with notable companies such as Genor Biopharma Co., Ltd. and Corning Incorporated. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in biopharmaceuticals and materials science.

Collaborations

Qing has collaborated with several professionals in her field, including Weihong Nian and Joe Zhou. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Qing Zhou's work exemplifies the spirit of innovation in the realms of biopharmaceuticals and materials science. Her patents and collaborations reflect her commitment to advancing technology for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…